Observational studies in human populations suggest that maternal zinc deficiency during pregnancy may cause adverse pregnancy outcomes for the mother and fetus. Therefore, we reviewed the current evidence from studies of zinc supplementation, with or without other micronutrients, during pregnancy and lactation to assess its impact on maternal, fetal, and infant health.
Background
The results of experimental studies conducted in animals and observational studies in human populations show that maternal zinc deficiency can have adverse effects on reproduction, including infertility, congenital anomalies, fetal growth retardation, prolonged labor, embryonic or fetal death, and early postnatal infant immune dysfunction. The possible mechanisms and pathways of maternal zinc deficiency and adverse health effects on the mother and fetus were previously reviewed [1] . On the basis of the new recommendations by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the International Atomic Energy Agency (IAEA), and the International Zinc Nutrition Consultative Group (IZiNCG) to use stunting rates of children under five as an indicator for the risk of zinc deficiency, it is estimated that approximately one-third of the world's population live in countries where the risk of zinc deficiency is high [2] . The prevalence of zinc deficiency among pregnant and lactating women worldwide is unknown.
Zinc requirements during pregnancy and lactation have been estimated from the zinc content of tissues accrued during pregnancy and the zinc content of milk secreted during lactation [3] . The estimated total additional zinc needed for pregnancy is ~100 mg [4] . In addition to the zinc accrued by the fetus, zinc is deposited in the placenta, amniotic fluid, and uterine S61 Zinc supplementation during pregnancy and lactation and mammary tissue. Approximately 60% of the total zinc is accumulated in the conceptus and 40% in the maternal tissue. The additional daily need increases during gestation to meet the demands for fetal growth, rising from ~0.1 mg/day additional zinc in the first quarter of pregnancy to ~0.7 mg/day additional zinc in the fourth quarter. As reviewed by Brown et al. [5] , the mean amount of zinc transferred in the breastmilk to exclusively breastfed infants declines rapidly from ~4 mg/day during the first few days of life to ~1.75 mg/day by 1 month. Zinc transfer declines more slowly thereafter to ~1 mg/day at 6 months. Studies suggest that maternal zinc absorption is increased and/or exogenous zinc excretion is decreased during pregnancy and lactation, thereby enhancing maternal zinc availability for fetal growth and milk zinc excretion [6, 7] . However, the ability of these homeostatic mechanisms to compensate for diets that are low in total zinc or in bioavailable zinc appears to be limited, so reproductive function may be compromised under these circumstances. In these cases, supplementation of women with low zinc intakes may be necessary to ensure optimal reproductive outcomes.
WHO currently recommends that all pregnant women in areas of high prevalence of malnutrition should routinely receive iron and folic acid supplements, together with appropriate dietary advice, to prevent anemia [8] . In view of the above-mentioned importance of zinc for human health and reproduction, we reviewed the impact of zinc supplementation on various reproductive outcomes in women from developed and developing countries to evaluate whether the addition of zinc to the iron and folic acid supplement should be considered. We compared the results of controlled intervention trials in which zinc was provided, with or without other micronutrients, to pregnant women. We further examined the impact of zinc supplementation during lactation on maternal and infant zinc status and zinc-related outcomes.
This paper is divided into four sections, which address the following questions in relation to zinc supplementation during pregnancy and lactation: Section 1: What is the effect of preventive zinc supplementation during pregnancy on maternal and neonatal health (i.e., maternal mortality, maternal morbidity, fetal growth, and postnatal growth and morbidity)? Section 2: What is the effect of preventive zinc supplementation during lactation on maternal and neonatal health? Section 3: Are there any adverse effects of zinc supplementation during pregnancy or lactation? Section 4: What are the implications of these outcomes for zinc supplementation programs during pregnancy and lactation and what are the remaining research needs?
Section 1
What is the effect of preventive zinc supplementation during pregnancy on maternal and neonatal health (i.e., maternal mortality, maternal morbidity, fetal growth, and postnatal growth and morbidity)?
Conclusions
The results of experimental studies in laboratory animals and observational studies in human populations both suggest that maternal zinc deficiency during pregnancy can cause adverse pregnancy outcomes for the mother, fetus, and/or newborn infant postnatally. A number of controlled intervention trials have now been completed in humans, but the results are difficult to interpret because of the relatively small number of studies reporting on each of these specific outcomes, the failure to characterize or stratify according to the women's preexisting zinc status and general nutritional condition, and the variable times of initiation, duration, and amount of zinc supplementation. With recognition of these limitations in the existing evidence base, the following conclusions can be drawn from the available studies.
A meta-analysis of supplementation trials indicates a small but significant positive impact of maternal zinc supplementation on the duration of pregnancy and a 14% reduction in premature delivery among zinc-supplemented women. Most available studies found no significant impact of maternal zinc supplementation on infant birthweight, but a subset of studies conducted in underweight or zinc-deficient women suggests that there may be a positive effect of zinc supplementation in such women. However, these results are quite limited, and more studies are needed to confirm these observations. There are inconsistent results with regard to other pregnancy outcomes, and the number of available studies is small, so no definitive conclusions are possible. Likewise, the impacts of maternal zinc supplementation during pregnancy on infant postnatal growth and the risk of infection are inconsistent and the number of studies is quite limited, so more research will be needed to allow definitive conclusions to be drawn, especially for the second half of infancy and later childhood.
Detailed review of evidence

Bibliographic search
Data sets were identified for this section by using a computerized bibliographic search (PubMed) with the key words zinc; limiting for human, English, clinical trial, meta-analysis, randomized, controlled trial. A total of 1,618 articles were identified during the PubMed search using these key words. Three additional manuscripts identified in other reviews of zinc S62 S. Y. Hess and J. C. King supplementation during pregnancy [9, 10] were also included, resulting in a total of 1,621 individual references. All titles and abstracts were reviewed. Of these, 44 articles evaluated the impact of zinc supplementation on pregnancy-related outcomes in the mother or infant. We excluded 2 of these 44 studies, 1 because the pregnant women chose the supplement themselves and 1 because the anemia status differed between treatment groups. The remaining 42 articles were then screened to combine those that presented data from the same intervention trial by using key characteristics, such as country, study population, and supplementation scheme. A total of 22 different trials were identified.
Maternal morbidity and mortality
The effect of supplemental zinc, with and without other micronutrients, on maternal morbidity and mortality was evaluated in 10 studies done over the past 30 years [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] (table 1) . With the exception of one study in Nepal [22, 23] , the supplement was taken daily from midpregnancy to term. In the study in Nepal [22, 23] , the supplement was started early in the first trimester. An additional study in Nepalese pregnant women investigated the impact of short-term zinc supplementation (3 weeks) in women who reported night-blindness [18] . The first zinc supplementation study by Jameson and Ursing [11] was not randomized, and the investigators were not blinded to treatment. In that study of Swedish women with anemia, 90 mg of supplemental zinc per day reduced complications at delivery, such as prolonged labor or excessive bleeding. Mahomed et al. [13] and Jonsson et al. [14] followed up on this observation by conducting two double-blind, randomized, controlled trials of zinc supplementation during pregnancy in England and Denmark, respectively. The women were given either 20 or 44 mg of zinc/day from booking to term. The outcomes evaluated included maternal bleeding, hypertension, and complications of labor and delivery. There was no evidence in either of these randomized, controlled trials that supplemental zinc affected maternal morbidity during pregnancy. Simmer et al. [16] , however, found a lower incidence of induced labor (13% vs. 50%) among zinc-supplemented (22.5 mg/day) UK women in a small, double-blind study with a total sample size of 56 women. In contrast, Dijkhuizen and Wieringa [17] found significantly more deliveries with complications in the group receiving zinc (30 mg/day) plus iron and folic acid than in the groups receiving iron and folic acid alone, iron and folic acid plus β-carotene, or iron and folic acid plus β-carotene and zinc. The differences among these studies may be related to the amount of supplemental zinc (90 vs. 20 or 44 mg/day), the initial zinc status of the mothers, the presence of other micronutrient supplements, obstetric practices, or investigator bias in the case of the nonblinded trial.
Hunt and coworkers [19] evaluated the effects of 20 mg of supplemental zinc/day during the last half of gestation on the incidence of pregnancy-induced hypertension. The incidence was significantly lower in the zinc-supplemented women (2% vs. 12%). Hogg et al. [20] also evaluated the effect of supplemental zinc (25 mg/day) in a larger population of poor African-American women in Alabama and found no effect on the incidence of pregnancy-induced hypertension between the two groups or on serum levels of homocysteine, an amino acid associated with occlusive vascular disease. Similarly, Castillo-Durán et al. [15] found no effect of zinc supplementation on the incidence of preeclampsia in pregnant Chilean adolescents who received 20 mg of supplemental zinc/day. A recent meta-analysis combining the results of seven randomized, controlled trials on pregnancy-induced hypertension and preeclampsia found no significant differences (relative risk, 0.83; 95% CI, 0.64 to 1.08) between the women receiving zinc and the women in the control group [10] . These limited data do not support a role of zinc in reducing hypertension or preeclampsia during gestation. Zinc plays an important role in maintaining normal immune function [24] . Therefore, maternal infection may be related to zinc status during pregnancy, and three studies have examined maternal infectious morbidity in relation to zinc supplementation.
Supplemental zinc did not alter the microbial growthpromoting properties of amniotic fluid [12] or the risk of malaria parasitemia among HIV-infected women [21] . Christian et al. [22] investigated the impact of micronutrient supplementation during pregnancy on the concentrations of acute-phase response proteins studied before supplementation and at 32 weeks of gestation in a large controlled trial in rural Nepal (779 women in five groups). Serum α 1 -acid glycoprotein concentration decreased in all groups but decreased more in the groups receiving folic acid, or folic acid and iron with or without zinc. In contrast, C-reactive protein increased in all groups from baseline to 32 weeks of gestation, but it was significantly lower in the group receiving folic acid and iron with zinc only [22] . This suggests that zinc given with folic acid and iron may ameliorate the inflammatory process in pregnancy, which has positive implications for reproductive health outcomes.
Serum zinc concentration declines progressively during the course of pregnancy in relation to bloodvolume expansion [25] . Thus, serum zinc concentration values must be interpreted in relation to the stage of pregnancy or serum albumin concentrations. Unlike studies in young children, in whom serum zinc concentration nearly always increases in response to zinc supplementation [26] , only 5 of the 12 zinc supplementation studies that reported serum zinc concentrations during pregnancy found a significant increase in the supplemented group [18, [27] [28] [29] [30] . The lack of response may have been due to failure to control for the stage of gestation or serum albumin concentration, in some cases, or to their relatively small sample sizes. Despite these limitations, serum zinc concentration is still the recommended biochemical indicator of zinc status during pregnancy at the population level [2] , and this indicator can be used to assess the impact of zinc supplementation in populations. A recent meta-analysis of nine studies of zinc supplementation in pregnant women found a significantly positive overall effect of supplementation on mean serum zinc concentration, with an effect size of 0.20 SD (95% CI, 0.051 to 0.348) [26] .
There are no studies of zinc supplementation and maternal mortality. The few studies of maternal morbidity reviewed here do not provide evidence that zinc supplements alone consistently reduce complications of labor and delivery, maternal hypertension, or infection. Since these pregnancy complications may be associated with placentation problems in early gestation, zinc supplementation prior to conception also should be evaluated in relation to maternal morbidity outcomes. However, no studies of zinc supplementation prior to and during gestation have been done to date.
Fetal mortality and growth
The effect of supplemental zinc on stillbirth or neonatal death has been reported in 7 studies, and 17 studies evaluated its effect on fetal growth [13, 15-17, 19, 23, 29-43] (table 2) . A recent meta-analysis found no overall impact on the rate of stillbirth or neonatal death [10] .
Most studies of supplemental zinc and fetal growth have used birthweight as the endpoint. Only three studies found that supplemental zinc significantly increased birthweight as compared with the control group [29, 30, 41] . All three studies were done in populations where maternal zinc depletion was likely. In the study comparing a zinc supplementation group with an untreated control group in India [30] , infants born to women in the control group weighed only about 2.6 kg; those born to zinc-supplemented mothers were about 0.3 to 0.8 kg heavier (p < .001), depending on the length of time supplemental zinc was provided. Xie et al. [29] compared three different levels of supplemental zinc (5, 10, and 30 mg/day) with placebo in rural Chinese women and found that the infants of mothers receiving the highest amount of zinc supplement (30 mg/ day) were on average 283 g heavier (p = .016) and had larger head circumferences (0.6 cm, p = .035) than the infants of mothers in the placebo group. This difference was not found in mothers receiving 5 or 10 mg of zinc/ day. Goldenberg et al. [41] studied the effect of zinc supplementation on birthweight in a group of African-American women who were medically indigent (without health insurance or other health-care coverage). Only women with plasma zinc concentrations below the median for their population at 20 weeks of gestation 
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Zinc supplementation during pregnancy and lactation were included in the study. Thus, the intervention was targeted toward women at risk for being zinc deficient. In all women, supplemental zinc increased the infant's birthweight by 128 g (p = .03) and head circumference by 0.4 cm (p = .02). The effect was greater in nonobese women, among whom zinc supplementation increased birthweight by 248 g (p = .005) and head circumference by 0.7 cm (p = .007). Eleven other studies failed to find a relationship between zinc supplementation and birthweight [13, 15, 17, 19, 31-34, 38, 39, 44] . However, none of those 11 studies stratified the effects of supplemental zinc on birthweight by maternal weight or zinc status.
There was no evidence that whether zinc was given along with other micronutrients or alone influenced the outcome. The recently published meta-analysis of 14 studies found that zinc supplementation had no significant impact on birthweight (WMD, −10.59; 95% CI, −36.71 to 15.54) [10] . Future studies are needed to determine if maternal pregravid or gravid weight modifies the effect of supplemental zinc on fetal growth and birthweight. Simmer et al. [16] conducted a double-blind trial in the United Kingdom of mothers at risk for delivering infants with intrauterine growth retardation because they had had a small-for-gestational age infant previously, were underweight, or were smoking. Zinc supplementation significantly reduced the incidence of intrauterine growth retardation (7% vs. 27%, p = .04). There was no significant effect on overall birthweight. Since this is a small study with insufficient power to allow definite conclusions to be drawn, additional research is needed to evaluate whether zinc supplementation is more likely to improve fetal growth in high-risk, underweight mothers.
Merialdi et al. [36] used ultrasonography to examine the effect of administration of supplemental zinc to pregnant women on fetal bone growth in utero. Although there were no effects of zinc supplementation (given along with iron and folic acid) on birthweight or head circumference, the femur diaphysis length was significantly longer in the fetuses of mothers receiving zinc along with iron and folic acid than in fetuses of mothers receiving iron and folic acid only at all time points measured between 20 and 38 weeks of gestation. No differences in birth length due to zinc supplementation were observed, but the small effects on femur length probably would not be detected in measurements of birth length. There were no other effects of supplemental zinc on growth at specific anatomical sites. These findings are consistent with studies in experimental animals suggesting that zinc has a very specific effect on the growth of long bones [45, 46] .
Preterm birth can contribute to a reduction in birthweight. Zinc supplementation significantly reduced the prematurity rate compared with placebo among Chilean adolescents (6% vs. 12%, p = .016) [15] . Among Indian women, there were significantly fewer preterm USA, 1983 [39 infants in the zinc-supplemented group than in a nonintervention control group who did not receive a placebo (2% vs. 11%, p < .05) [30] . Although most other studies found no significant overall impact on preterm delivery, some studies found a beneficial impact in selected subgroups of women. In a meta-analysis of 13 studies, Mahomed et al. [10] found a small, but significant, reduction in preterm birth (relative risk, 0.86; 95% CI, 0.76 to 0.98). This 14% reduction in preterm birth among zinc-supplemented women was found primarily in the subset of studies involving lower-income women, suggesting that zinc supplementation may be beneficial in areas where poor nutrition and maternal infection are more common. Animal studies show that zinc is essential for neurologic development in utero. In two studies in Peru, Merialdi et al. [35, 37] evaluated the effect of supplemental zinc on fetal heart rate and fetal movement, using novel methods for measuring fetal cardiac and somatic activity, both of which are influenced by the development of the autonomic nervous system. Fetuses of mothers who received supplemental zinc plus iron and folic acid showed an increased range and variability of fetal heart rate and an increased amount of time spent moving compared with those whose mothers received iron and folic acid supplements without zinc. The differences became significant at 36 weeks of gestation (p < .05). Although follow-up studies are needed to verify these observations and assess their longer-term implications, the data suggest that adding zinc to prenatal iron and folic acid supplements may have a beneficial effect on fetal neurobehavioral development.
In summary, the effects of supplemental zinc on maternal labor and delivery complications and on fetal growth and neurobehavioral development are limited and conflicting. There is some evidence that supplemental zinc increases birthweight and duration of gestation in underweight women living in areas where zinc intake is low or zinc is poorly absorbed. However, a number of other studies failed to find a relationship between supplemental zinc, with or without other micronutrient supplements, and birthweight. The results of those studies were not stratified by maternal body weight.
Neonatal and early infant morbidity and mortality, growth, and development
The effects of zinc supplementation on postnatal growth, development, and rates of infections are summarized in table 3 [9, 42, [47] [48] [49] [50] [51] [52] . Osendarp et al. [47] evaluated the effects of zinc supplementation on infant growth and morbidity at 6 months of age in Bangladesh. Maternal supplementation during pregnancy reduced the risk of infant acute diarrhea (risk ratio, 0.84; 95% CI, 0.72 to 0.98), dysentery (risk ratio, 0.36; 95% CI, 0.25 to 084), and impetigo (risk ratio, 0.53; 95% CI, 0.34 to 0.82) in low-birthweight infants but not in infants with normal birthweight. The results from the Peruvian maternal zinc supplementation trial, which were published in a review article [9] , also show that maternal zinc supplementation reduced acute diarrhea and dysentery, but the results were only significant for the period from 8 to 12 months of age. In a study in rural Nepal, the women received supplements from early pregnancy to 3 months postpartum that contained vitamin A alone; vitamin A and folic acid; vitamin A, folic acid, and iron; vitamin A, folic acid, iron, and zinc; or a multiple micronutrients (MMN) supplement [48] . None of the combinations of antenatal micronutrient supplements affected symptoms of neonatal morbidity in the first 10 days of life or at 6 weeks of age [48] , and there was no evidence that zinc had any effect on infant mortality throughout the first year [42] . These findings suggest that maternal zinc supplementation during pregnancy may influence the infant's risk of selected infections postnatally, but that these benefits may be restricted to older infants. More research is needed to address these issues.
In two studies, no differences in infant growth were observed in relation to maternal zinc supplementation among Indonesian infants at 6 months postpartum [51] and among Bangladeshi children at 13 months postpartum [47] . In contrast, infants born to Peruvian mothers supplemented with zinc during pregnancy had significantly greater anthropometric measures from months 4 to 12 [50] . On average, the infants from the zinc group were 0.58 ± 0.12 kg/month heavier, with weight accrued during the first year of life, than those from the control group. The longitudinal effects of zinc treatment remained significant for weight, calf and chest circumferences, and calf muscle area after control for a range of covariates, including infant-feeding practices and diarrhea morbidity. The reason for these differences among studies is not known, and additional research will be needed to understand the effects.
Neurobehavioral development was evaluated in infants born to zinc-supplemented Bangladeshi [49] and Peruvian women [9] . In Peru, some improvements in infant neurobehavioral development (novelty preference) were observed in the zinc-supplemented group at 6 months of age, whereas no benefit was observed in Bangladesh. In fact, Bangladeshi infants in the placebo group had higher scores on mental development and psychomotor indexes than those in the zinc-supplemented group. Tamura et al. [52] evaluated the effect of prenatal zinc supplementation on the mental and psychomotor development of 355 children of African-American mothers who participated in a double-blind study of zinc supplementation in which the infants of zinc-supplemented mothers had increased head circumference at birth. There was no effect on mental or psychomotor development of the children at 5 years of age, before or after stratification of the sample by maternal body mass index. Identification 
Section 2
What is the effect of preventive zinc supplementation during lactation on maternal and neonatal health?
Conclusions
The limited data available on zinc supplementation and lactation performance and infant growth and zinc status fail to show any consistent benefit to the mother or child. However, studies are available only from relatively healthy women in developed countries. The effect of maternal zinc supplementation during pregnancy and lactation or during lactation only on maternal and neonatal health needs to be studied in undernourished women.
Detailed review of evidence Bibliographic search
Data sets were identified as described above. Of the 1,618 articles, there were 3 articles that evaluated the impact of zinc supplementation during lactation. Two additional articles not identified during the PubMed search were added. The findings of the five articles are summarized in the following section (table 4) .
All five studies of the effect of maternal zinc supplementation on milk zinc concentration and infant growth [53] [54] [55] [56] [57] were done in women living in developed countries (Finland and the United States). Zinc supplementation was initiated at birth and continued daily throughout the duration of the studies, which varied from 6 to 12 months. It is not clear whether the mothers were exclusively breastfeeding for the entire study period or whether breastfeeding was supplemented with formula and complementary foods during the later stages of lactation.
Milk volume and zinc concentration
Krebs et al. [53] found that the rate of decline in milk zinc concentrations was significantly less in mothers receiving supplemental zinc without any other micronutrients than in non-zinc-supplemented mothers (p = .02). Log-transformed monthly milk zinc concentrations were compared between the two groups to determine the mean differences in rate of decline between birth and 9 months of age. Milk zinc concentration decreased by 0.69 ± 0.27 µg/mL in the nonzinc-supplemented group, whereas it declined by 0.54 ± 0.14 µg/mL in the supplemented group. These changes in milk zinc concentration with zinc supplementation occurred without any increase in maternal plasma zinc levels. The other four studies gave supplemental zinc to lactating women along with other micronutrients. Karra et al. [54] provided 25 mg of supplemental zinc per day to lactating women for 6 months and found a significantly lower decline in breastmilk zinc concentration in the supplemented group than in the placebo group, accompanied by a significant increase in plasma zinc concentration in the zinc-supplemented mothers. Salmenperä et al. [56] found no difference in breastmilk zinc concentrations between the control group and the supplemented group receiving 20 mg of zinc per day. However, breastmilk zinc concentration in the group receiving 40 mg per day declined significantly more slowly-by 6 months-than in the other two groups. There was no correlation between maternal serum zinc concentration and the total zinc transfer into milk in any of the three groups (40, 20, and 0 mg/day) [56] . Krebs et al. [57] and Moser-Veillon and Reynolds [55] did not find an effect of supplemental zinc on milk zinc concentration. These inconsistent findings suggest that neither maternal zinc intake nor plasma zinc levels are major determinants of milk zinc concentration.
Infant growth and zinc status
Only one study is available regarding the effect of maternal zinc supplementation during lactation on infant growth. Salmenperä et al. [56] found no effect of maternal zinc supplementation (20 or 40 mg/day vs. placebo) during lactation on serum zinc concentrations or growth of Finnish infants. Infant serum zinc concentrations throughout the first year of life (mean ± SD, 67 ± 4 μg/dL) tended to decline during periods of rapid growth, especially in boys. There were no associations between serum zinc concentrations and growth rates.
Section 3
Are there any adverse effects of zinc supplementation during pregnancy or lactation?
Conclusions
There is very little information available on adverse effects of zinc supplementation during pregnancy. We reviewed the effects of providing zinc in a prenatal supplement on iron status in nine randomized, doubleblind, controlled trials and on copper status in four trials. None of these studies found a difference in final hemoglobin, serum ferritin, transferrin receptor, or serum copper concentration between the zinc-supplemented group and the control group. The four studies reporting on copper status provided information on serum copper concentration only, which is a relatively insensitive biomarker of copper status. Further studies using more sensitive indicators of copper status are required. On the basis of available results, it can be concluded that the addition of zinc to a prenatal iron and folic acid supplement does not adversely affect iron status.
Detailed review of evidence
Any adverse effects related to the addition of zinc to the prenatal iron and folic acid supplement would be of concern. It is important, therefore, to consider the risks, as well as the benefits, of zinc supplementation during pregnancy and lactation. However, manifestations of acute toxicity symptoms, such as nausea and vomiting, occur only at very high zinc intake levels of ~225 to 450 mg/day or more [58] . An adverse effect of zinc on copper metabolism has been shown only at zinc intakes above 50 mg/day in adults, as measured by a decrease in erythrocyte superoxide dismutase activity [59] . There is some evidence from intervention trials in young children that iron indicators do not improve as much when supplemental iron is given with zinc as when iron is given alone [60] , although no overall effect was found in a recent meta-analysis [61] .
A recent animal study showed that supplementation of zinc-adequate dams with additional zinc induced a immunosuppressive response in the offspring, a finding that needs further investigation but implies a need for caution [62] . The impact of adding zinc to prenatal supplements on iron and copper nutriture was reviewed. A total of nine randomized, double-blind controlled trials in pregnant women [13, 17, 19, 32, 44, [63] [64] [65] [66] [67] reporting results on either hemoglobin concentration or other iron status indicators are summarized in table 5. One study was not considered in this analysis because the supplementation period was only 3 weeks [18] and, therefore, was not likely to have an impact on hemoglobin concentration. For all other studies, we present the data of the two treatment groups differing by zinc only, if the studies included more than two groups. Two studies [13, 32] compared zinc versus placebo, four studies compared the addition of zinc to an iron [63] or an iron and folic acid supplement [17, 65] with vitamin A or β-carotene [17, 66] , and four studies provided a MMN supplement containing iron and folic acid, with or without zinc [19, 44, 64, 67] . One study found that the addition of zinc to an iron supplement had a beneficial impact on hemoglobin concentration in anemic pregnant Iranian women after 12 weeks of supplementation [63] . None of the other studies found a difference in final hemoglobin, serum ferritin, or transferrin receptor concentration between the treatment group receiving zinc and those receiving no zinc (with or without other micronutrients). Dijkhuizen et al. [51] also evaluated maternal and infant micronutrient status 6 months postpartum and found that the addition of zinc to the prenatal supplement had no impact on hemoglobin or plasma ferritin concentration in mothers and infants. On the basis of these results, it can be concluded that the addition of zinc to a prenatal iron and folic acid or a MMN supplement in the range of 15 to 30 mg of zinc/day does not adversely affect iron status.
The studies reporting on copper status provide information on serum copper concentration only, which is the least sensitive biomarker of copper status [68] . Of the three studies reporting on copper status (table 5), none of the studies found a significant difference in final serum copper concentration between the two treatment groups receiving MMN with or without zinc. Similarly, Hambidge et al. [39] stated that there was not a difference between groups at 10 months of gestation, but they did not provide the data disaggregated by treatment group. This limited information, as judged by serum copper levels, indicates that the provision of supplemental zinc at a level of 20 to 30 mg/day during pregnancy does not have a negative effect on copper status. Further studies using more sensitive indicators of copper status are needed.
None of the zinc supplementation trials in lactating women reported results on iron or copper status in the mothers. However, on the basis of the lack of any adverse effects on iron and copper status in pregnant women and in children [61] , it can be assumed that providing a zinc supplement during lactation at the recommended dosage does not have an adverse effect on maternal iron or copper status.
Section 4
What are the implications of these outcomes for zinc supplementation programs during pregnancy and lactation and what are the remaining research needs?
Adding zinc to prenatal supplements
As mentioned above, WHO recommends that all pregnant women living in areas of high prevalence of malnutrition should routinely receive iron and folic acid supplements to prevent anemia as part of the integrated management of pregnancy and childbirth [8] . The purpose of this review was to evaluate the potential benefits and adverse effects of adding zinc to the prenatal supplement containing iron and folic acid and to draw conclusions for programmatic implications.
There is currently no evidence of adverse effects of supplemental zinc on iron status or the response to iron supplementation during pregnancy. A metaanalysis showed that zinc supplementation during pregnancy reduced the risk of preterm birth by 14% [10] . However, the effects of supplemental zinc on labor and delivery complications, birthweight, and postnatal [13] , where SD was not reported. c. Results for serum ferritin are reported as geometric mean (-1 SD, +1 SD) for Peru 1999 [65] , as median (interquartile range) for Indonesia 2001 [17] and Nepal 2003 [22, 66] , and as mean ± SD for USA 1985 [67] .
d. The study by Hambidge et al. [39] is not shown in this table because the data on copper concentration are not disaggregated between the two treatment groups. However, the authors state that there was no significant difference between final concentrations at 10 months of gestation.
e. No significant difference in final concentration between two treatment groups f. No significant difference in final concentration among all four treatment groups. g. Additional information provided by author (Christian P, personal communication, 2007). h. P-value calculated on the basis of changes in copper concentration. i. Results reported only for women who were studied long enough to take supplements for more than 60 days. j. MMN content of supplement not defined.
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S. Y. Hess and J. C. King growth are inconsistent. In view of the lack of a clear benefit of supplemental zinc during gestation, a recommendation to add zinc to the usual prenatal supplement of iron and folic acid cannot be made. Nevertheless, since toxic effects of supplemental zinc have not been identified, it may be prudent to include zinc in the prenatal supplement in areas at high risk for zinc deficiency, as indicated by a stunting rate of more than 20% among children under five [2] or a maternal body mass index under 18.5.
Zinc supplementation during lactation
There is currently insufficient evidence for any benefit in providing zinc supplements to lactating women. Further research is needed to assess the impact of zinc supplementation on the lactating mothers and their infants, in particular among undernourished women living in lower-income countries.
Research needs
» There is a need for further research on the addition of zinc to prenatal supplements of iron and folic acid for undernourished or low-weight women in lowerincome countries. » Future studies are needed to determine if maternal pregravid or gravid weight is a determinant of the effect of supplemental zinc on fetal growth and birthweight. The association between maternal stature, zinc status, and birthweight also needs further investigation. » Since pregnancy complications may be associated with placentation problems in early gestation, zinc supplementation prior to conception also should be evaluated in relation to maternal morbidity outcomes. » Future studies on zinc supplementation during pregnancy should include a follow-up during early childhood to further evaluate the impact on growth, development, and morbidity in infants of mothers who have received zinc supplementation during pregnancy. » It is further important to assess the risks as well as the benefits of zinc supplementation during pregnancy and lactation. » The effect of maternal zinc supplementation during lactation on maternal and neonatal health needs to be studied in undernourished women.
